Bermejo-Jambrina M, van der Donk L, van Hamme J, Wilflingseder D, de Bree G, Prins M
EMBO J. 2024; 43(7):1135-1163.
PMID: 38418557
PMC: 10987522.
DOI: 10.1038/s44318-024-00061-0.
Delviks-Frankenberry K, Ojha C, Hermann K, Hu W, Torbett B, Pathak V
Mol Ther Nucleic Acids. 2023; 33:794-809.
PMID: 37662965
PMC: 10470399.
DOI: 10.1016/j.omtn.2023.08.007.
Schobel H, Diem G, Kiechl J, Chiste D, Bertacchi G, Mayr A
J Hosp Infect. 2023; 135:11-17.
PMID: 36754288
PMC: 10041887.
DOI: 10.1016/j.jhin.2022.12.023.
Lakhashe S, Amacker M, Hariraju D, Vyas H, Morrison K, Weiner J
Front Immunol. 2022; 13:788619.
PMID: 35273592
PMC: 8902080.
DOI: 10.3389/fimmu.2022.788619.
Bertacchi G, Posch W, Wilflingseder D
Biomolecules. 2022; 12(2).
PMID: 35204813
PMC: 8868603.
DOI: 10.3390/biom12020313.
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis.
Phelps M, Balazs A
Front Immunol. 2021; 12:734304.
PMID: 34603314
PMC: 8479175.
DOI: 10.3389/fimmu.2021.734304.
Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque.
Virnik K, Zhou W, Medvedev A, Walsh G, Perry-Anderson J, Majam V
Biochem Biophys Res Commun. 2021; 577:58-63.
PMID: 34507066
PMC: 10167915.
DOI: 10.1016/j.bbrc.2021.08.052.
On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder.
Uversky V
Arch Virol. 2021; 166(5):1283-1296.
PMID: 33606110
PMC: 7892713.
DOI: 10.1007/s00705-021-04984-5.
HIV-1 subverts the complement system in semen to enhance viral transmission.
Nijmeijer B, Bermejo-Jambrina M, Kaptein T, Ribeiro C, Wilflingseder D, Geijtenbeek T
Mucosal Immunol. 2021; 14(3):743-750.
PMID: 33568786
PMC: 8075950.
DOI: 10.1038/s41385-021-00376-9.
Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
Drouin A, Migraine J, Durand M, Moreau A, Burlaud-Gaillard J, Beretta M
J Virol. 2020; 95(5).
PMID: 33298540
PMC: 8092819.
DOI: 10.1128/JVI.01994-20.
CR4 Signaling Contributes to a DC-Driven Enhanced Immune Response Against Complement-Opsonized HIV-1.
Bermejo-Jambrina M, Blatzer M, Jauregui-Onieva P, Yordanov T, Hortnagl P, Valovka T
Front Immunol. 2020; 11:2010.
PMID: 32922405
PMC: 7457048.
DOI: 10.3389/fimmu.2020.02010.
SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.
Featherstone A, Aiken C
J Virol. 2020; 94(20).
PMID: 32796070
PMC: 7527050.
DOI: 10.1128/JVI.00594-20.
The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies.
Cavarelli M, Le Grand R
Hum Vaccin Immunother. 2020; 16(9):2018-2032.
PMID: 32614649
PMC: 7553688.
DOI: 10.1080/21645515.2020.1765622.
Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
Joshi V, Newman R, Pack M, Power K, Munro J, Okawa K
PLoS Pathog. 2020; 16(5):e1008577.
PMID: 32392227
PMC: 7241850.
DOI: 10.1371/journal.ppat.1008577.
HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury P, Novikova M, Alfadhli A, Hikichi Y, Kagiampakis I, KewalRamani V
J Virol. 2019; 94(1).
PMID: 31619553
PMC: 6912099.
DOI: 10.1128/JVI.01526-19.
Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies.
Zhu H, Mathew E, Connelly S, Zuber J, Sullivan M, Piepenbrink M
PLoS One. 2019; 14(9):e0221550.
PMID: 31504041
PMC: 6736307.
DOI: 10.1371/journal.pone.0221550.
Folding Molecular Dynamics Simulation of a gp41-Derived Peptide Reconcile Divergent Structure Determinations.
Georgoulia P, Glykos N
ACS Omega. 2019; 3(11):14746-14754.
PMID: 31458149
PMC: 6643504.
DOI: 10.1021/acsomega.8b01579.
Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope.
Rudometov A, Chikaev A, Rudometova N, Antonets D, Lomzov A, Kaplina O
Vaccines (Basel). 2019; 7(3).
PMID: 31390770
PMC: 6789618.
DOI: 10.3390/vaccines7030083.
Germinality does not necessarily define mAb expression and thermal stability.
Schwaigerlehner L, Mayrhofer P, Diem M, Steinfellner W, Fenech E, Oostenbrink C
Appl Microbiol Biotechnol. 2019; 103(18):7505-7518.
PMID: 31350616
PMC: 6719414.
DOI: 10.1007/s00253-019-09998-3.
Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.
Schonfeld M, Knackmuss U, Chandorkar P, Hortnagl P, Hope T, Moris A
Front Immunol. 2019; 10:1123.
PMID: 31178863
PMC: 6542955.
DOI: 10.3389/fimmu.2019.01123.